Eli Lilly and Company

NYSE:LLY

Sector

🏥 Health Care

Industries

🧬 Biotechnology

🔬 Clinical Trials

🧠 Mental Health

💊 Pharmaceuticals

🔍 Research & Consulting

💉 Vaccines

Location

United States

Market Cap

USD 682.35 B

Share Price

USD 760.08

Avg Daily Volume

3,833,001

Change (1 day)

-0.38%

Change (1 year)

-3.81%

Change (YTD)

-1.54%

Eli Lilly and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2025: USD 9.32 B

Eli Lilly and Company Operating Cash Flow is USD 9.32 B for the Trailing 12 Months (TTM) ending March 31, 2025, a 153.50% change year over year. Operating cash flow is cash generated from the company’s regular business operations.

Eli Lilly and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2024 was USD 3.68 B, a -41.80% change year over year.
Eli Lilly and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 6.32 B, a -21.66% change year over year.
Eli Lilly and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 8.06 B, a 3.17% change year over year.
Eli Lilly and Company Operating Cash Flow for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 7.81 B, a 59.23% change year over year.